Outcomes from the TITAN Study in mCSPC

Outcomes from the TITAN Study in mCSPC

User Photo
obr

1 year
107 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
William Oh, MD, Chief of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai discusses the outcomes of the TITAN study in metastatic castration-sensitive prostate cancer (mCSPC).
Up Next Autoplay
>